Related Experiment Video
Updated: Aug 14, 2025

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.3K
Marked Response to Larotrectinib in Pelvic Spindle Cell Sarcoma With Concurrent TPM3-NTRK1 Fusion and CDK4/MDM2
Wen-Kuan Huang1, Shih-Chiang Huang2, Chien-Ming Chen3
1Division of Hematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
JCO Precision Oncology
|January 18, 2023
Abstract
No abstract available in PubMed .

